Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript May 10, 2023
Operator: Good day, ladies and gentlemen. And welcome to the Pieris Pharmaceuticals to host First Quarter 2023 Investor Call. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host Tom Bures, CFO. Sir, the floor is yours.
Thomas Bures: Thank you. Good morning, everyone, and thank you for joining us for our first quarter 2023 conference call and corporate update. On...
